Posted:
10/13/2024, 4:20:54 PM
Location(s):
Connecticut, United States ⋅ New York, United States ⋅ California, United States ⋅ Collegeville, Pennsylvania, United States ⋅ Bothell, Washington, United States ⋅ Groton, Connecticut, United States ⋅ New York, New York, United States ⋅ Pennsylvania, United States ⋅ Washington, United States ⋅ San Diego, California, United States
Experience Level(s):
Senior
Field(s):
Growth & Marketing
ROLE SUMMARY:
BRAFTOVI (encorafenib) & MEKTOVI (binimetinib) are key to therapies within the Pfizer Oncology Precision Medicine franchise, with a strong future of growth through the end of the decade
The portfolio covers three indications:
Metastatic Melanoma: BRAFTOVI + MEKTOVI received approval in BRAF mutant metastatic melanoma in 2018
Colon Cancer: BRAFTOVI + cetuximab received approval as the first and only targeted therapy in 2L+ BRAF mutant metastatic colorectal cancer in April 2020; an earlier line indication is expected in the 2024-25 timeframe
Lung Cancer: BRAFTOVI + MEKTOVI received approval for BRAF mutant metastatic lung cancer in 2023
There is significant growth expected from this portfolio over the next 3-4 years and will be an important priority brand within Pfizer Oncology
The Director, BRAF Melanoma Marketing & Pan-Tumor will report to the US Mel/CRC Marketing Team Lead
This position requires strong strategic, analytical and execution skills, interpersonal and communication skills, and agility to learn and work across multiple stakeholders
ROLE RESPONSIBILITIES:
The Director, BRAF Melanoma Marketing & Pan-Tumor will partner with the Melanoma Indication Lead and Mel/CRC Marketing TL to deliver on key BRAFTOVI & MEKTOVI Melanoma strategies, as well as drive multiple pan-tumor marketing efforts across the three indications of BRAFTOVI & MEKTOVI.
Melanoma focused responsibilities include:
Lead development and execution of Melanoma promotional efforts across both all key stakeholders (ie HCPs, and Consumer marketing patients, health systems)
Collaborate and provide insight with Melanoma Strategy Lead in development of Melanoma Strategy for BRAFTOVI & MEKTOVI
Engage with field team members and KOLs as appropriate to stay up-to-date on Melanoma competitive landscape and key business drivers
Collaborate with ISE (Insights Strategy & Execution) Team to derive insights from market research and performance and analytics reports across the Melanoma business.
Pan-Tumor focused responsibilities include:
Collaborate with indication leads on the development of Media Strategy (HCP and Consumer) and lead execution of media tactics with agency(s)
Lead peer-to-peer strategy and third party programs, including management of speaker prog ram content and speaker bureaus
Liaise with Account and Payer Marketing teams to ensure that brand strategies are carried through for execution executed by those marketing teams.
BASIC QUALIFICATIONS:
BA/BS required and 10+ years of pharmaceutical marketing experience
Experience in working with different channels i.e. digital
Has demonstrated experience that focus on the customer and leverages innovative ways of reaching those customers
Strong project management skills, including ability to lead multiple projects simultaneously
Ability to translate strategy and analysis to a tactical, executable level to drive brand success
Strong team player with demonstrated ability to collaborate with experts from cross-functional areas
Strong business acumen with excellent verbal and written communication skills for a wide variety of audiences, including senior management, including negotiation skills
High-energy, proactive self-starter who has the initiative to function autonomously and the confidence and ingenuity to initiate, create, and innovate
Demonstrated ability to manage advertising and other agencies to produce communications resources that impact business performance
PREFERRED QUALIFICATIONS:
Advanced degree preferred
Understanding of advanced on Melanoma landscape preferred
Previous in-line US/global Marketing experience preferred
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS:
Limited travel (10-20%) will be required for customer meetings, congresses and internal engagements
Other Job Details:
Last date to apply is October 27, 2024
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Website: https://www.pfizer.com/
Headquarter Location: New York, New York, United States
Employee Count: 10001+
Year Founded: 1849
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine